Current Location: Home > NEWS

The company has been committed to steroid hormone-led drugs

Time: 2022-04-26
The company has been committed to the product development strategy dominated by steroid hormone drugs, with the direction of cardiovascular and cerebrovascular drugs, anti-tumor and antidepressant drugs.
PreviousBack Next

Copyright(C)2022, Hangzhou Shuyuan Pharmaceutical Technology Co., Ltd. All Rights Reserved.

Home
About Us
Products
Contact Us
Tel